A Disturbing Case of Genetic Mutation in Sperm Donation
A man with a genetic mutation linked to cancer unknowingly transmitted this mutation to at least 67 offspring through various fertility clinics in Europe. Alarmingly, around 10 of these children have already been diagnosed with different forms of cancer, including leukemia and non-Hodgkin lymphoma.
This troubling situation emerged when two families reached out to their fertility clinics after their children were diagnosed with cancer. Genetic tests confirmed the presence of a rare mutation in the TP53 gene, a gene critical for tumor suppression.
Further investigation unearthed that the donor himself carried the same mutation, which is related to Li-Fraumeni syndrome—a serious hereditary condition that drastically elevates cancer risk in young individuals.
It was later found that 67 children had been conceived using this donor’s sperm, distributed among 46 families across eight countries in Europe. Of these children, 23 were identified as carrying the mutation, and unfortunately, ten have already developed cancer. Most of these children were born between 2008 and 2015, suggesting the donor’s sperm had been in circulation for several years without adequate oversight.
Currently, those children who have the TP53 mutation are under rigorous medical supervision. This includes comprehensive MRIs of the body and brain, regular ultrasound screenings once they reach adulthood, and frequent clinical assessments. Doctors recommend avoiding certain imaging methods, like mammograms, due to the risks they pose to those with Li-Fraumeni syndrome.
The Mutation’s Background
The mutation in question wasn’t recognized as a cancer risk back in 2008, thus it slipped through the cracks of routine donor screenings. Remarkably, not all of the donor’s sperm contained the mutation, indicating a phenomena called germline mosaicism—where a genetic change exists in the reproductive cells, but not in the rest of the body.
This phenomenon means that a donor can inadvertently pass on severe hereditary conditions. There’s been another incident where a donor transmitted a mutation that causes neurofibromatosis type 1, which is known for leading to both skin tumors and pigment changes.
The sperm bank that provided the donor’s samples typically limits each donor to 75 families, a figure that lacks solid backing in international law. Even after identifying the mutation, the sperm bank chose not to reveal how many children were born to the donor, raising concerns that more might be affected and unaware of their risk.
The Regulatory Landscape
Variations in regulations between countries complicate the situation even further. While France limits donors to 10 births and Germany to 15, many places lack these restrictions entirely. In fact, private sperm banks often operate with their own diverse guidelines, allowing for numerous births from a single donor—even across different international borders. Without a unified system, many families remain oblivious to shared genetic vulnerabilities.
This case underscores the hazards of cross-border sperm donation and the absence of robust regulatory measures. It not only poses the risk of hereditary diseases spreading but also makes it challenging to track affected children and guarantee crucial medical follow-up.
In France, medical authorities suggest seeking fertility treatments in countries where donations are closely monitored by public health systems. Donations must be anonymous, voluntary, without compensation, and undergo strict medical evaluations for both donors and recipients. Furthermore, transferring reproductive cells requires special authorization from the national bioethics agency.
Current Situation in Israel
Israel lacks enforceable laws governing the number of families that can use a single sperm donor. Existing guidelines, which originate from the Health Ministry and individual sperm banks, are the only framework in place. Each bank sets its own limit as a way to curb unintentional familial connections, such as half-siblings marrying unknowingly.
Dr. Eran Altman, the director of the sperm bank at Rabin Medical Center, conveyed earlier this year that the focus should be less on the volume of samples a donor provides and more on how many families end up conceiving with that donor’s sperm. This, he believes, should be the core of regulatory efforts. He also warned of the dangers prompted by inconsistent governmental actions leading to varying rules among sperm banks.
For instance, the sperm bank at Tel Aviv Sourasky Medical Center restricts donors to 10 families, yet many Israeli women look to foreign sperm banks—often through local agents—where the limits can stretch anywhere from 25 to 75 families, or even more.
Despite this, experts in Israel like Dr. Yigal Madjar advise against the use of imported sperm. He pointed out that the statistical risk of genetic disorders increases with foreign sperm donors, as one donor might father hundreds of children worldwide, making it nearly impossible to trace them if a hereditary condition arises.
In contrast, Israeli donors are recorded by the Health Ministry, have exclusivity agreements, and cannot donate to multiple local banks—this setup effectively minimizes the risks of duplication and fraud.
Although there have been announcements to cap each donor at 10 families and various private bills proposed, no law has yet been enacted.
While this instance is reportedly rare, specialists like Dr. Madjar caution that similar occurrences could happen again without strict international regulations. They advocate for legally limiting the number of children per donor, ensuring full transparency, coordination across countries, and consistent medical monitoring for affected families.
